Medtronic is strengthening its long-standing collaboration with GE HealthCare through a new multi-year agreement, aiming to enhance patient monitoring capabilities and accelerate innovation across critical care, perioperative, and ambulatory healthcare environments.
Medtronic has extended GE HealthCare’s rights to use its monitoring technologies, including pulse oximetry, brain monitoring, capnography, and regional oximetry. The agreement builds on a 2012 deal with Covidien, now part of Medtronic, further deepening integration across multiple healthcare platforms.
The technologies will be integrated into GE HealthCare platforms such as FlexAcuity, Carescape Canvas, and Carevance monitors. Applications include bedside, telemetry, ambulatory monitoring, maternal-infant care, and advanced perioperative solutions, expanding clinical capabilities and improving monitoring accuracy across diverse healthcare settings.
Both companies plan to accelerate development by incorporating next-generation Nellcor pulse oximetry and BIS Advance brain monitoring technologies. Their R&D roadmap also includes expansion into wireless wearable technologies and anesthesia airway visualization, supporting innovation in patient monitoring and enabling more connected and data-driven healthcare solutions.
GE HealthCare’s patient care solutions team will collaborate with Medtronic’s acute and monitoring group to commercialize these technologies. The joint initiatives aim to accelerate clinical transformation, reduce healthcare costs, and harmonize technology platforms while improving efficiency and delivering better outcomes for patients worldwide.
Medtronic continues to expand its monitoring partnerships, with companies like Baxter, Philips, Siemens Healthineers, and Stryker also using its technologies, alongside a recently expanded agreement with Mindray.
